Odborné zdroje

Grossman J et al. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinits, alone and in combination with other perennial rhinits medications. J Allergy Clin Immunol 1995;95“1123-7.

Eccles R et al. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. Sep-Oct 2008;22(5):491-6.

Klöcker N et al. Evaluation of protective and therapeutic effects of dexpanthenol on nasal decongestants and preservatives: results of cytotoxic studies in vitro. Am J Rhinol. Sep-Oct 2004;18(5):315-20.

Verse T et al. Die Verträglichkeit von Nasalia unter besonderer Berücksichtigung des Einflusses von Konservierungsmitteln und physikalisch-chemischen Parametern. Laryngorhinootologie 2003; 82(11): 782-789.

Ching-Yin Ho et al. In Vitro Effects of Preservatives in Nasal Sprays on Human Nasal Epithelial Cells. American Journal of Rhinology,Volume: 22 issue: 2, page(s): 125-129.

Görkem Eskiizmir et al. A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects. Eur J Clin Pharmacol. 2011 Jan;67(1):19-23.

Bende M., Löth S. Vascular effects of topical oxymetazoline on human nasal mucosa. The Journal of Laryngology & Otology , Volume 100 , Issue 3 , March 1986 , pp. 285 – 288.

Fokkens WJ et al. European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. July 2007. Rhinology 45(2):97-101.

Vokurka J et al. Šetrná dekongestiva a šetrné podání dekongestiv. Otorinolaryng. a Foniat. /Prague/, 59, 2010, No. 3, pp. 136-141.

Bende M, Löth S. Vascular effects of topical oxymetazoline on human nasal mucosa. The Journal of Laryngology and Otology. 100 (3): 285–8.

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 552. ISBN 9783527607495.

Fischer, Janos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 552. ISBN 9783527607495. Archived from the original on 29 December 2016.